{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:40:48Z","timestamp":1779900048189,"version":"3.53.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R03 HD110743"],"award-info":[{"award-number":["R03 HD110743"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.reprotox.2025.109070","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:26:13Z","timestamp":1758770773000},"page":"109070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Embryotoxicity analysis of anti-arrhythmia drugs amiodarone, dronedarone, and their metabolites using 3D gastruloid models"],"prefix":"10.1016","volume":"138","author":[{"given":"Courtney Kehaulani","family":"Kurashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5720-5806","authenticated-orcid":false,"given":"Yusuke","family":"Marikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib1","article-title":"The gene ontology knowledgebase in 2023","volume":"224","author":"Aleksander","year":"2003","journal-title":"Genetics"},{"key":"10.1016\/j.reprotox.2025.109070_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ydbio.2022.05.002","article-title":"Gastruloids: pluripotent stem cell models of mammalian gastrulation and embryo engineering","volume":"488","author":"Arias","year":"2022","journal-title":"Dev. Biol."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The gene ontology consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet"},{"issue":"3","key":"10.1016\/j.reprotox.2025.109070_bib4","first-page":"117","article-title":"Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans","volume":"7","author":"Brennan","year":"1991","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14573\/altex.2009.1.3","article-title":"Food for thought\u2026 on the economics of animal testing","volume":"26","author":"Bottini","year":"2009","journal-title":"ALTEX"},{"issue":"2","key":"10.1016\/j.reprotox.2025.109070_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/molecules28020621","article-title":"Drug metabolism of Hepatocyte-like organoids and their applicability in In vitro toxicity testing","volume":"28","author":"Bouwmeester","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.reprotox.2025.109070_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/ijpvm.IJPVM_179_17","article-title":"Dietary supplements and cardiovascular diseases","volume":"9","author":"Bronzato","year":"2018","journal-title":"Int J. Prev. Med"},{"issue":"7","key":"10.1016\/j.reprotox.2025.109070_bib8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3949\/ccjm.70.7.624","article-title":"Amiodarone induced thyrotoxicosis: diagnostic and therapeutic strategies","volume":"70","author":"Cardenas","year":"2003","journal-title":"Cleve Clin. J. Med"},{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5334\/gh.1288","article-title":"The heart of the world","volume":"19","author":"Di Cesare","year":"2024","journal-title":"Glob. Heart"},{"key":"10.1016\/j.reprotox.2025.109070_bib10","unstructured":"FDA (U.S. Food and Drug Administration). 2018. CORDARONE\u00ae (amiodarone) tablets: Prescribing Information. \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/018972s054lbl.pdf\u3009 (Accessed on 6\/19\/2025)."},{"key":"10.1016\/j.reprotox.2025.109070_bib11","unstructured":"FDA (U.S. Food and Drug Administration). 2023. MULTAQ\u00ae (dronedarone) tablets: Prescribing Information. \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/022425s028s030lbl.pdf\u3009 (Accessed on 6\/19\/2025)."},{"key":"10.1016\/j.reprotox.2025.109070_bib12","unstructured":"FDA (U.S. Food and Drug Administration). 2025. FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs. \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs\u3009 (Accessed on 6\/20\/2025)."},{"key":"10.1016\/j.reprotox.2025.109070_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116513","article-title":"The ion channel basis of pharmacological effects of amiodarone on myocardial electrophysiological properties, a comprehensive review","volume":"174","author":"Gelman","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.reprotox.2025.109070_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fphar.2016.00039","article-title":"Effects of amiodarone and N-desethylamiodarone on cardiac Voltage-Gated sodium channels","volume":"7","author":"Ghovanloo","year":"2016","journal-title":"Front Pharm."},{"key":"10.1016\/j.reprotox.2025.109070_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4137\/CMC.S8445","article-title":"Pleiotropic effects of antiarrhythmic agents: dronedarone in the treatment of atrial fibrillation","volume":"7","author":"Heijman","year":"2013","journal-title":"Clin. Med Insights Cardiol."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.reprotox.2010.01.009","article-title":"Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing","volume":"30","author":"Hettwer","year":"2010","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.reprotox.2025.109070_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0300-483X(91)90085-F","article-title":"Effects of amiodarone administration during pregnancy in fischer 344 rats","volume":"65","author":"Hill","year":"1991","journal-title":"Toxicology"},{"key":"10.1016\/j.reprotox.2025.109070_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/toxsci\/kfaf093","article-title":"Detection of developmental toxicity of the anti-COVID-19 drug molnupiravir using gastruloid-based in vitro assays","volume":"207","author":"Huntsman","year":"2025","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.reprotox.2025.109070_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108558","article-title":"Validation of a mouse 3D gastruloid-based embryotoxicity assay in reference to the ICH S5(R3) guideline chemical exposure list","volume":"125","author":"Huntsman","year":"2024","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2025.109070_bib20","unstructured":"ICH (the International Council for Harmonisation) of Technical Requirements for Pharmaceuticals for Human Use. S5(R3) guideline on reproductive toxicology: Detection of toxicity to reproduction for human pharmaceuticals Step 5. 2020. \u3008https:\/\/www.ema.europa.eu\/en\/ich-s5-r3-guideline-detection-reproductive-and-developmental-toxicity-human-pharmaceuticals-scientific-guideline\u3009. (Accessed on 6\/18\/2025)."},{"issue":"9","key":"10.1016\/j.reprotox.2025.109070_bib21","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00018-010-0619-9","article-title":"Teratogenic effects of thalidomide: molecular mechanisms","volume":"68","author":"Ito","year":"2011","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.reprotox.2025.109070_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.taap.2018.07.006","article-title":"Embryoid body test with morphological and molecular endpoints implicates potential developmental toxicity of trans-resveratrol","volume":"355","author":"Kim","year":"2018","journal-title":"Toxicol. Appl. Pharm."},{"issue":"2","key":"10.1016\/j.reprotox.2025.109070_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/toxsci\/kfab112","article-title":"Dolutegravir impairs stem Cell-Based 3D morphogenesis models in a manner dependent on dose and timing of exposure: an implication for its developmental toxicity","volume":"184","author":"Kirkwood-Johnson","year":"2021","journal-title":"Toxicol. Sci."},{"issue":"15","key":"10.1016\/j.reprotox.2025.109070_bib24","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1242\/dev.112367","article-title":"Retinoic acid controls body axis extension by directly repressing Fgf8 transcription","volume":"141","author":"Kumar","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.reprotox.2025.109070_bib25","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1101\/gad.907301","article-title":"The murine winged helix transcription factors, Foxc1 and Foxc2, are both required for cardiovascular development and somitogenesis","volume":"15","author":"Kume","year":"2001","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.reprotox.2025.109070_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.2009.03381.x","article-title":"Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity","volume":"67","author":"Lafuente-Lafuente","year":"2009","journal-title":"Br. J. Clin. Pharm."},{"issue":"11","key":"10.1016\/j.reprotox.2025.109070_bib27","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/mrd.22423","article-title":"Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil","volume":"81","author":"Lau","year":"2014","journal-title":"Mol. Reprod. Dev."},{"issue":"6","key":"10.1016\/j.reprotox.2025.109070_bib28","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/bcp.15670","article-title":"Development and verification of a physiologically based pharmacokinetic model of dronedarone and its active metabolite N-desbutyldronedarone: application to prospective simulation of complex drug-drug interaction with rivaroxaban","volume":"89","author":"Leow","year":"2023","journal-title":"Br. J. Clin. Pharm."},{"issue":"12","key":"10.1016\/j.reprotox.2025.109070_bib29","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/mrd.22585","article-title":"An in vitro gastrulation model recapitulates the morphogenetic impact of pharmacological inhibitors of developmental signaling pathways","volume":"82","author":"Li","year":"2015","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.reprotox.2025.109070_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.reprotox.2016.09.015","article-title":"Adverse effect of valproic acid on an in vitro gastrulation model entails activation of retinoic acid signaling","volume":"66","author":"Li","year":"2016","journal-title":"Reprod. Toxicol."},{"issue":"14","key":"10.1016\/j.reprotox.2025.109070_bib31","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/bdr2.1712","article-title":"Methoxyacetic acid inhibits histone deacetylase and impairs axial elongation morphogenesis of mouse gastruloids in a retinoic acid signaling-dependent manner","volume":"112","author":"Li","year":"2020","journal-title":"Birth Defects Res"},{"issue":"5","key":"10.1016\/j.reprotox.2025.109070_bib32","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.tiv.2008.04.009","article-title":"Application of a metabolizing system as an adjunct to the rat whole embryo culture","volume":"22","author":"Luijten","year":"2008","journal-title":"Toxicol. Vitr."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/toxsci\/kfy174","article-title":"Pluripotent stem cells in developmental toxicity testing: a review of methodological advances","volume":"165","author":"Luz","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"19","key":"10.1016\/j.reprotox.2025.109070_bib34","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1242\/dev.00687","article-title":"The concerted action of meox homeobox genes is required upstream of genetic pathways essential for the formation, patterning and differentiation of somites","volume":"130","author":"Mankoo","year":"2003","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.reprotox.2025.109070_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/dvg.20473","article-title":"Aggregated P19 mouse embryonal carcinoma cells as a simple in vitro model to study the molecular regulations of mesoderm formation and axial elongation morphogenesis","volume":"47","author":"Marikawa","year":"2009","journal-title":"Genesis"},{"key":"10.1016\/j.reprotox.2025.109070_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.reprotox.2019.10.004","article-title":"Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells","volume":"91","author":"Marikawa","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2025.109070_bib37","first-page":"1","article-title":"Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?","volume":"8","author":"Mc Namara","year":"2019","journal-title":"Integr. Pharm. Res Pr."},{"issue":"3","key":"10.1016\/j.reprotox.2025.109070_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1460-9568.2003.02765.x","article-title":"Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen","volume":"18","author":"McCaffery","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.reprotox.2025.109070_bib39","article-title":"Bioavailability of dronedarone tablets administered with or without food in healthy participants","volume":"45","author":"Naccarelli","year":"2024","journal-title":"Am. Heart J."},{"key":"10.1016\/j.reprotox.2025.109070_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4137\/CMC.S6677","article-title":"Safety and efficacy of dronedarone in the treatment of atrial fibrillation\/flutter","volume":"5","author":"Naccarelli","year":"2011","journal-title":"Clin. Med Insights Cardiol."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.CIR.77.1.200","article-title":"The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction","volume":"77","author":"Nattel","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.reprotox.2025.109070_bib42","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1242\/dev.129.15.3563","article-title":"Embryonic retinoic acid synthesis is required for forelimb growth and anteroposterior patterning in the mouse","volume":"129","author":"Niederreither","year":"2002","journal-title":"Development"},{"issue":"20","key":"10.1016\/j.reprotox.2025.109070_bib43","doi-asserted-by":"crossref","DOI":"10.1242\/dev.200933","article-title":"In vitro models of human development and their potential application in developmental toxicity testing","volume":"149","author":"Niethammer","year":"2022","journal-title":"Development"},{"key":"10.1016\/j.reprotox.2025.109070_bib44","unstructured":"NIH (National Institutes of Health). NIH to prioritize human-based research technologies: New initiative aims to reduce use of animals in NIH-funded research. 2025. \u3008https:\/\/www.nih.gov\/news-events\/news-releases\/nih-prioritize-human-based-research-technologies\u3009 (Accessed on 6\/20\/2025)."},{"issue":"21","key":"10.1016\/j.reprotox.2025.109070_bib45","doi-asserted-by":"crossref","first-page":"8182","DOI":"10.3390\/ijms21218182","article-title":"Application of in vitro metabolism activation in High-Throughput screening","volume":"21","author":"Ooka","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.reprotox.2025.109070_bib46","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1592\/phco.30.9.904","article-title":"Dronedarone: a new antiarrhythmic agent","volume":"30","author":"Oyetayo","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.reprotox.2025.109070_bib47","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.109.858027","article-title":"Dronedarone","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.reprotox.2025.109070_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2022.100074","article-title":"Pluripotent stem cell assays: modalities and applications for predictive developmental toxicity","volume":"3","author":"Piersma","year":"2022","journal-title":"Curr. Res Toxicol."},{"issue":"3","key":"10.1016\/j.reprotox.2025.109070_bib49","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-62-3-563","article-title":"Iodine kinetic studies during amiodarone treatment","volume":"62","author":"Rao","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.reprotox.2025.109070_bib50","doi-asserted-by":"crossref","first-page":"E402","DOI":"10.1001\/amajethics.2022.402","article-title":"What should dietary supplement oversight look like in the US?","volume":"24","author":"Richardson","year":"2022","journal-title":"AMA J. Ethics"},{"issue":"2","key":"10.1016\/j.reprotox.2025.109070_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/1559325819852243","article-title":"Cardioprotective potential of Plant-Derived molecules: a scientific and medicinal approach","volume":"17","author":"Shah","year":"2019","journal-title":"Dose Response"},{"key":"10.1016\/j.reprotox.2025.109070_bib52","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fphar.2020.00422","article-title":"Herbal Medicine for cardiovascular diseases: efficacy, mechanisms, and safety","volume":"11","author":"Shaito","year":"2020","journal-title":"Front Pharm."},{"issue":"4","key":"10.1016\/j.reprotox.2025.109070_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104328","article-title":"Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessment","volume":"30","author":"Shenton","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"16","key":"10.1016\/j.reprotox.2025.109070_bib54","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/clc.23768","article-title":"Predictors of dronedarone plasma drug concentrations and effect on atrial fibrillation\/atrial flutter recurrence: analyses from the EURIDIS and ADONIS studies","volume":"45","author":"Thind","year":"2022","journal-title":"Clin. Cardiol."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/pro.4218","article-title":"PANTHER: making genome-scale phylogenetics accessible to all","volume":"31","author":"Thomas","year":"2022","journal-title":"Protein Sci."},{"issue":"3","key":"10.1016\/j.reprotox.2025.109070_bib57","first-page":"519","article-title":"Incorporating new approach methodologies into regulatory nonclinical pharmaceutical safety assessment","volume":"40","author":"Turner","year":"2023","journal-title":"ALTEX"},{"issue":"7","key":"10.1016\/j.reprotox.2025.109070_bib58","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.tcm.2016.03.014","article-title":"Amiodarone and dronedarone: an update","volume":"26","author":"Vamos","year":"2016","journal-title":"Trends Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.reprotox.2025.109070_bib59","first-page":"845","article-title":"Limitations of animal studies for predicting toxicity in clinical trials","volume":"4","author":"Van Norman","year":"2019","journal-title":"Is. it Time Rethink Our Curr. Approach? JACC Basic Transl. Sci."},{"issue":"8","key":"10.1016\/j.reprotox.2025.109070_bib60","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/17531934231177425","article-title":"Thalidomide upper limb embryopathy - pathogenesis, past and present management and future considerations","volume":"48","author":"Vargesson","year":"2023","journal-title":"J. Hand Surg. Eur. Vol."},{"key":"10.1016\/j.reprotox.2025.109070_bib61","first-page":"508","article-title":"Clinical utility of plasma amiodarone level measurement: a single center experience","volume":"2","author":"Wang","year":"2011","journal-title":"Innov. Card. Rythm Manag"},{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/toxsci\/kfx034","article-title":"Exposure-Based validation of an in vitro gastrulation model for developmental toxicity assays","volume":"157","author":"Warkus","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.reprotox.2025.109070_bib63","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/toxsci\/kfy143","article-title":"Fluoxetine inhibits canonical wnt signaling to impair embryoid body morphogenesis: potential teratogenic mechanisms of a commonly used antidepressant","volume":"165","author":"Warkus","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.reprotox.2025.109070_bib64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/toxsci\/kfv209","article-title":"Use of in vitro morphogenesis of mouse embryoid bodies to assess developmental toxicity of therapeutic drugs contraindicated in pregnancy","volume":"149","author":"Warkus","year":"2016","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.reprotox.2025.109070_bib65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10557-009-6189-0","article-title":"Dronedarone: a promising alternative for the management of atrial fibrillation","volume":"23","author":"Yalta","year":"2009","journal-title":"Cardiovasc Drugs Ther."},{"issue":"8","key":"10.1016\/j.reprotox.2025.109070_bib66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.freeradbiomed.2012.02.002","article-title":"Effect of early acute high concentrations of iodide exposure on mitochondrial superoxide production in FRTL cells","volume":"52","author":"Yao","year":"2012","journal-title":"Free Radic. Biol. Med"},{"issue":"Pt 1","key":"10.1016\/j.reprotox.2025.109070_bib67","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.fct.2017.09.023","article-title":"Developmental toxicity assessment of common excipients using a stem cell-based in vitro morphogenesis model","volume":"109","author":"Yuan","year":"2017","journal-title":"Food Chem. Toxicol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623825002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623825002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:46:28Z","timestamp":1762314388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623825002412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":67,"alternative-id":["S0890623825002412"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2025.109070","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Embryotoxicity analysis of anti-arrhythmia drugs amiodarone, dronedarone, and their metabolites using 3D gastruloid models","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2025.109070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109070"}}